Growth Opportunities for Global Antimicrobial Technologies Enabled by COVID-19

Description

Innovation Culture and Growth Strategies Catalyzed to Prevent Infections

Antimicrobial technology has previously seen wide adoption in antimicrobial additives, coatings, and films in consumer health applications. However, with the emergence of COVID-19, the demand for antimicrobial technology has driven innovations, such as graphene nanoparticles (NPs), photocatalytic additives, and antimicrobial polymer nanomaterials, in developing high-temperature resistance, non-toxic antimicrobial disinfectants, and long-lasting antimicrobial technology adoption in consumer health, building and construction, automotive, and consumer goods applications. Antimicrobial technology materials include antimicrobial polymers; composites, metal-based antimicrobial agents; nanomaterials; natural-based antimicrobial agents; antimicrobial peptides (AMPs); and other materials, such as phenolics, amidines, and biguanides.

Due to their stable structure, metal ions and metal-oxide ions have found use in medical and food packaging applications. The use of ultra-thin two-dimensional materials like black phosphorus and graphene on antimicrobial surfaces has been a focus of technology development initiatives following the outbreak of COVID-19. In addition to antimicrobial surfaces, implants, medical devices, food packaging, building and construction materials, and textiles have all experienced a spike in interest for antimicrobial coatings. The need for active packaging that exhibits high antimicrobial features for food and personal care applications following COVID-19 has prompted industry stakeholders and researchers to continue pursuing their work with natural antimicrobials such as chitin-chitosan and peptides to develop biodegradable, safe, yet high-performance antimicrobial films.

The research will answer the following questions:

What factors will drive antimicrobial technology adoption post COVID-19?

What challenges and impediments restrain antimicrobial technology adoption?

What initiatives are industry participants undertaking to accelerate adoption across industries?

What previous challenges does antimicrobial technology adoption across applications address?

What growth potential exists for commercializing antimicrobial technologies across industries?

Product Code: DA4D

Strategic Imperatives

Why Is It Increasingly Difficult to Grow?The Strategic Imperative 8™: Factors Creating Pressure on Growth
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on Antimicrobial Technologies Enabled by COVID-19
Growth Opportunities Fuel the Growth Pipeline Engine™
Research Methodology

Research Scope and Segmentation

Research Context and Key Questions the Study Will Answer
Research Segmentation

Research Summary

Technology Dashboard
Impact of COVID-19 on the Antimicrobial Technologies Landscape
COVID-19 Drives Interest in Antimicrobial Technologies across Regions
Key Findings

Growth Opportunity Analysis: Impact of COVID-19 on Antimicrobial Technologies

COVID-19 Has Resulted in an Unprecedented Demand for Antimicrobial Technologies
Accelerated AMR Risk and Infection Spread Propelled Antimicrobial Use in Emerging Markets Pre- and During COVID-19
Technologies to Accommodate Antimicrobial Features in Various Applications
Metal Ions, Polymers, Naturals, AMPs, and Nanoantimicrobials Could Act as Disruptors to Mitigate Infections
Technologies Could Solve Existing AMR Challenges Post-COVID-19
Mode of Action of Antimicrobials Defines Clinical Efficacy via Syntheses
Antimicrobials Pave the Way for a New Application Landscape beyond Healthcare
Regulatory Aspects Make High-performance Antimicrobial Commercialization Time-consuming

Technology Assessment: Antimicrobial Technologies

Metal Ions, Especially Copper and Ag, Help Create New Antimicrobial Technologies
Interest in Metal and Metal-oxide Ion Adoption as an Antimicrobial for Their Stable Structure
Nanomaterials Provide Multiple Bactericidal Pathways to Combat Microbes and Infections
Antimicrobial Nanomaterials for High-performance Solutions
Food Quality and Safety Awareness Create Demand for Natural Antimicrobials
Interest in Use of Natural Antimicrobial Materials for Degradable Antimicrobial Technology
The Multifaceted Nature of AMPs Drives Their Long-term Applicability
AMP Adoption Is Increasing in Healthcare and Food Packaging Applications
Antimicrobial Polymers Have Proven Capabilities to Protect Against the Negative Impact of Pathogenic Microorganisms
Simplifying Antimicrobial Polymer Fabrication and Application Processes
To Evaluate the Effect of Antimicrobial Susceptibility on Outcomes, Benchmarking Key Performance Indicators Is Pivotal
Antimicrobial Agents' Relevance in Various Industrial Sectors

Innovation Ecosystem

Commercialized Metal-ion Antimicrobial Technologies
High-performance Antimicrobial Coating Development Using Metal Ions
Nanomaterials for Cost-efficient, High-performance Antimicrobial Technology Development
Studies Focusing on Antimicrobial Nanomaterial Adoption in Food and Energy Applications
Increase in Degradable Antimicrobial Film Development
Stakeholders Investigating the Potential Adoption of Antimicrobial Peptides for Food Packaging
High Interest in Research Studies on Antimicrobial Polymers in APAC
Antimicrobial Coatings Remain an Area of High R&D

IP Analysis

Steady Rise in Research Studies Related to Antimicrobial Technologies
Metal Ions and Natural Antimicrobial Technologies Lead in IP Filing across the Globe
US and European Patent Offices Show Steady Rise in IP Filings in Last 5 Years
Natural Antimicrobials Are Gaining IP Focus Because of Increased Interest in Developing Environment-friendly Technologies

Funding and Investment Analysis

Investors Bet Big on Antimicrobials to Reinforce Health and Safety During the Pandemic
Funding Is Predominantly Inclined towards New Product Innovation
Healthcare Companies Are Prominent Beneficiaries to Investigate Enhanced Antimicrobials for Combatting AMR
Antimicrobial Spending to Escalate to Eliminate Superbug Threats
Government Initiatives and Funding and Private Funding Encourage Cost-efficient Antimicrobial Technology Development
Accelerators and Incubators Expedite Material and Digitization Initiative Growth

Growth Opportunity Universe

Growth Opportunity 1: Ultra-thin, Durable, High-performance Antimicrobial Technology Development
Growth Opportunity 1: Ultra-thin, Durable, High-performance Antimicrobial Technology Development (continued)
Growth Opportunity 2 Nanomaterial Integration During Fabrication for Cost-efficient and High-performance Antimicrobial Technologies
Growth Opportunity 2: Nanomaterial Integration During Fabrication for Cost-efficient and High-performance Antimicrobial Technologies (continued)
Growth Opportunity 3: R&D Activities to Use Metal and Metal-oxide Ions to Develop Self-sanitizing Technology
Growth Opportunity 3: R&D Activities to Use Metal and Metal-oxide Ions to Develop Self-sanitizing Technology (continued)
Growth Opportunity 4: Digital Interventions on Antimicrobial Stewardship Can Drive New Product Development
Growth Opportunity 4: Digital Interventions on Antimicrobial Stewardship Can Drive New Product Development (continued)

Appendix

Technology Readiness Levels (TRL): Explanation

Next Steps

Your Next Steps
Why Frost, Why Now?
Legal Disclaimer